MNKD

#4528
MannKind Corporation - Common Stock
0.0 4 USD
-98.96%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
0.04
0.04
Range Annuel
0.03
6.51
Changement quotidien
-98.96%
Changement Mensuel
-98.63%
Evolution sur 6 mois
-99.30%
Changement Annuel
-99.29%
Clôture Précédente
3.6 4
Open
0.0 4
Low
0.0 4
High
0.0 4
Volume
179
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 11.65 M
  • Employee 592
  • Founded N/A
  • CEO Michael Castagna
  • Website www.mannkindcorp.com
  • Headquarter Delaware, United States
  • FIGI BBG000PPL3G9
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
283.5
ratio cours/chiffre d'affaires
5.25

MannKind Corporation - Common Stock

MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991. MannKind Corporation was named after its founder, Alfred E. Mann.

Nouvelles